Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Total Debt (2019 - 2025)

Historic Total Debt for Puma Biotechnology (PBYI) over the last 7 years, with Q3 2025 value amounting to $33.7 million.

  • Puma Biotechnology's Total Debt fell 5681.59% to $33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.7 million, marking a year-over-year decrease of 5681.59%. This contributed to the annual value of $67.0 million for FY2024, which is 3272.06% down from last year.
  • As of Q3 2025, Puma Biotechnology's Total Debt stood at $33.7 million, which was down 5681.59% from $44.9 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Total Debt registered a high of $100.1 million during Q2 2021, and its lowest value of $33.7 million during Q3 2025.
  • Over the past 5 years, Puma Biotechnology's median Total Debt value was $97.7 million (recorded in 2022), while the average stood at $86.8 million.
  • In the last 5 years, Puma Biotechnology's Total Debt skyrocketed by 60093.1% in 2021 and then plummeted by 5681.59% in 2025.
  • Puma Biotechnology's Total Debt (Quarter) stood at $97.1 million in 2021, then grew by 1.25% to $98.3 million in 2022, then rose by 1.37% to $99.7 million in 2023, then crashed by 32.72% to $67.0 million in 2024, then plummeted by 49.71% to $33.7 million in 2025.
  • Its Total Debt was $33.7 million in Q3 2025, compared to $44.9 million in Q2 2025 and $56.0 million in Q1 2025.